Citadel Advisors’s Fractyl Health GUTS Stock Holding History

Citadel Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,016	Closed	-$22.1K	–	15036
2026 Q1	$22.1K	Sell	4,016 -15,066	-79%	-$167K	﹤0.01%	12650
2025 Q4	$504K	Sell	19,082 -129,448	-87%	-$2.5M	﹤0.01%	9000
2025 Q3	$2.83M	Buy	+148,530	New	+$2.31M	﹤0.01%	5404
2025 Q2	–	Sell	-8,362	Closed	-$119K	–	15473
2025 Q1	$119K	Sell	8,362 -52,639	-86%	-$1.01M	﹤0.01%	11211
2024 Q4	$1.51M	Sell	61,001 -7,568	-11%	-$211K	﹤0.01%	6211
2024 Q3	$2.08M	Buy	68,569 +2,714	+4%	+$106K	﹤0.01%	5455
2024 Q2	$3.37M	Sell	65,855 -76,131	-54%	-$5.88M	﹤0.01%	4374
2024 Q1	$12.6M	Buy	+141,986	New	+$14.3M	﹤0.01%	2623

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's GUTS Position: Q2 2026 in Review

Citadel Advisors sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 4,016 shares — an estimated $22.1K sold.

Citadel Advisors first reported a position in GUTS in Q1 2024 and held it in 8 quarters. The position peaked at $12.6M in Q1 2024. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Citadel Advisors reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 4,016 Fractyl Health shares in Q2 2026, an estimated $22.1K.
Citadel Advisors first reported a position in Fractyl Health in Q1 2024 and held it in 8 quarters.
Citadel Advisors's Fractyl Health position peaked at $12.6M in Q1 2024.
79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.